Olga Frankfurt MD
Assistant Professor in Medicine-Hematology/Oncology, Northwestern University Medical School
Join to View Full Profile
675 N Saint Clair StSuite 21-100Chicago, IL 60611
Phone+1 312-695-0990
Dr. Frankfurt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2002 - 2005
Rush University Medical CenterResidency, Internal Medicine, 1999 - 2002
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1999
Certifications & Licensure
FL State Medical License 2022 - 2028
IL State Medical License 2002 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2012-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017
Clinical Trials
- Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Start of enrollment: 2006 Jun 01
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Start of enrollment: 2006 Aug 01
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia Start of enrollment: 2007 Nov 15
Publications & Presentations
PubMed
- CLO25-058: First-in-Human, Multicenter Phase 1 Study of the Bromodomain 2 Inhibitor ABBV-744 in Relapsed/Refractory Acute Myeloid Leukemia.Anjali Advani, Olatoyosi Odenike, Deepa Jeyakumar, Raya Mawad, Olga Frankfurt
Journal of the National Comprehensive Cancer Network. 2025-03-28 - 8 citationsDevimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trial.Timothy S Pardee, Bayard L Powell, Richard A Larson, Joseph Maly, Michael Keng
Blood Neoplasia. 2024-06-01 - Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.Jessica K Altman, Tsila Zuckerman, Jamie Koprivnikar, James McCloskey, Vamsi Kota
Blood Advances. 2023-12-26
Journal Articles
- Venetoclax Combined with Decitabine or Azacitidine in Treatment-Naive, Elderly Patients with Acute Myeloid LeukemiaBrian A Jonas, Courtney D DiNardo, Olga Frankfurt, Daniel A Pollyea, Keith Pratz, Anthony Letai, Martha Arellano, Marina Konopleva, Hagop M Kantarjian, Blood
Abstracts/Posters
- Aspacytarabine (BST-236) Is Safe and Efficacious As a Single-Agent, First-Line Therapy for Patients with Acute Myeloid Leukemia Unfit for Standard Chemotherapy. Integr...Olga Frankfurt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- High Rate of IDH1 Mutation Clearance and Measurable Residual Disease Negativity in Patients with IDH1-Mutant Newly Diagnosed Acute Myeloid Leukemia Treated with Ivosid...Olga Frankfurt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Apellis Announces U.S. FDA Approval of Empaveli (Pegcetacoplan) for Adults with Paroxysmal Nocturnal HemoglobinuriaMay 20th, 2021- Apellis Announces U.S. Food and Drug Administration (FDA) Approval of EMPAVELI™ (Pegcetacoplan) for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)May 14th, 2021
Midday Fix: Campaign 2 Save Lives – Event to Help Those Battling LeukemiaMay 15th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
